Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 12-2012 | |
| Operating Expenses | 592 | 603 | 874 | 0 | 0 |
| Operating Income | -592 | -603 | -874 | N/A | N/A |
| Interest Expense | 170 | 62 | 32 | 0 | 0 |
| Other Income | 1,112 | 18 | 3 | 0 | 0 |
| Pre-tax Income | 350 | -647 | -903 | 0 | 0 |
| Net Income Continuous | 350 | -647 | -903 | N/A | N/A |
| Minority Interests | 41 | 58 | 59 | N/A | N/A |
| Net Income | $310 | $-705 | $-962 | $N/A | $N/A |
| EPS Basic Total Ops | 8,582.57 | -20,619.75 | -2,536.99 | N/A | N/A |
| EPS Basic Continuous Ops | 9,704.44 | -18,978.52 | -2,405.56 | N/A | N/A |
| EPS Diluted Total Ops | 8,582.57 | -20,619.75 | -2,536.99 | N/A | N/A |
| EPS Diluted Continuous Ops | 9,704.44 | -18,978.52 | -2,405.56 | N/A | N/A |
| EBITDA(a) | $-592 | $-602 | $-874 | $N/A | $N/A |